title: Reply to the letter to the editor 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance' by Funck-Brentano et al.
authors.affiliation: Department of Dermatology and Research Unit EA 4340 'Biomarkers in Cancerology and in Hemato-oncology', AP-HP Ambroise Paré Hospital and University of Versailles-Saint-Quentin-en-Yvelines, Boulogne-Billancourt.
authors.forename: E
authors.initials: E
authors.lastname: Funck-Brentano
authors.affiliation: Department of Toxicology, AP-HP Raymond Poincaré Hospital and University of Versailles-Saint-Quentin-en-Yvelines, Garches.
authors.forename: J C
authors.initials: JC
authors.lastname: Alvarez
authors.affiliation: Department of Dermatology and Research Unit EA 4340 'Biomarkers in Cancerology and in Hemato-oncology', AP-HP Ambroise Paré Hospital and University of Versailles-Saint-Quentin-en-Yvelines, Boulogne-Billancourt.
authors.forename: C
authors.initials: C
authors.lastname: Longvert
authors.affiliation: Department of Toxicology, AP-HP Raymond Poincaré Hospital and University of Versailles-Saint-Quentin-en-Yvelines, Garches.
authors.forename: E
authors.initials: E
authors.lastname: Abe
authors.affiliation: Department of Public Health, AP-HP Ambroise Paré Hospital and University of Versailles-Saint-Quentin-en-Yvelines, Boulogne-Billancourt.
authors.forename: A
authors.initials: A
authors.lastname: Beauchet
authors.affiliation: Department of Dermatology and Research Unit EA 4340 'Biomarkers in Cancerology and in Hemato-oncology', AP-HP Ambroise Paré Hospital and University of Versailles-Saint-Quentin-en-Yvelines, Boulogne-Billancourt.
authors.forename: P
authors.initials: P
authors.lastname: Saiag
authors.affiliation: Department of Pharmacology and CIC-1421, AP-HP, Pitié-Salpêtrière Hospital, Paris INSERM, CIC-1421 and UMR ICAN 1166, Paris Faculty of Medicine, Sorbonne Universités, UPMC Univ Paris 06, Paris, France christian.funck-brentano@upmc.fr.
authors.forename: C
authors.initials: C
authors.lastname: Funck-Brentano
mesh_terms: D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000097:blood*; D008297:Male; D008545:Melanoma / Q000097:blood* / Q000188:drug therapy*; D009154:Mutation / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000097:blood* / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage* / Q000097:blood*
chemical_list: D007211:Indoles; D013449:Sulfonamides; D048493:Proto-Oncogene Proteins B-raf